Download Free Sample Report

Zebrafish Transgenesis and Gene Editing Services Market, Global Outlook and Forecast 2023-2030

Zebrafish Transgenesis and Gene Editing Services Market, Global Outlook and Forecast 2023-2030

  • Published on : 22 January 2023
  • Pages :109
  • Report Code:SMR-7541263

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The zebrafish is an important and widely used vertebrate model organism in scientific research, for example in drug development, in particular pre-clinical development. It is also notable for its regenerative abilities, and has been modified by researchers to produce many transgenic strains.
This report contains market size and forecasts of Zebrafish Transgenesis and Gene Editing Services in Global, including the following market information:
Global Zebrafish Transgenesis and Gene Editing Services Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Zebrafish Transgenesis and Gene Editing Services market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Disease Modeling
Genetic Functional Studies
Target Gene ValidationDisease Modeling Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Zebrafish Transgenesis and Gene Editing Services include Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech and Bioreperia, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zebrafish Transgenesis and Gene Editing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zebrafish Transgenesis and Gene Editing Services Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Zebrafish Transgenesis and Gene Editing Services Market Segment Percentages, by Type, 2022 (%)
Disease Modeling
Genetic Functional Studies
Target Gene ValidationDisease Modeling
Genetic Functional Studies
Target Gene Validation
Global Zebrafish Transgenesis and Gene Editing Services Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Zebrafish Transgenesis and Gene Editing Services Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Biotechnology
Global Zebrafish Transgenesis and Gene Editing Services Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Zebrafish Transgenesis and Gene Editing Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zebrafish Transgenesis and Gene Editing Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Zebrafish Transgenesis and Gene Editing Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories